Introduction
Striking the balance in 24-hour movement behaviour (sedentary behaviour, physical activity and sleep) is expected to reduce the risk of recurrent major cardiovascular event or death (MACE). We aim to determine the (cost-)effectiveness of the RISE intervention for secondary prevention of MACE in community dwelling people at risk with first-ever stroke by improving 24-hour movement behaviour.
Methods
This assessor-blinded multicentre randomised controlled trial includes 1000 participants with first-ever stroke, of whom 752 high-risk participants (who are sedentary and inactive based on their 24-hour movement behaviour) are randomised to the experimental group (RISE intervention) or control (usual care) group. RISE is a 15 week-blended behavioural intervention: 120 primary care physiotherapists coach people in their home setting using behaviour change techniques and the RISE eCoaching system. This system consists of 1) an activity monitor, 2) a smartphone application that provides real-time feedback and contains e-learning modules, and 3) a monitoring dashboard for the physiotherapist. A close relative is involved during the intervention to provide participatory support. This intervention was co-designed with stroke survivors.
The primary outcome is effectiveness of the RISE intervention regarding prevention of MACE measured at one year post-randomisation using survival analysis comparing experimental and control group. Secondary outcomes include cost-effectiveness for MACE prevention and QALYs and changes in 24-hour movement behaviour over time using Compositional Data Analysis.
Conclusion
This study offers the foundation of implementation of the RISE intervention in post-stroke care. The integration of behaviour change techniques, the RISE eCoaching system, participatory support, and extensively trained physiotherapists is expected to establish a sustainable movement behavioural change and thereby contribute to the prevention of MACE
Relevance
A sustainable 24-hour movement behaviour change is needed to lower MACE in patients with stroke. Assessing the (cost-)effectiveness of the RISE intervention will offer a foundation for implementation in standard post-stroke care.